Health-care innovator and leader Glenn D. Steele Jr, MD, PhD, has been elected Board Chair at City of Hope. Dr. Steele joined the City of Hope Board of Directors in 2016 and was Chair of the Executive Compensation and Governance Committee from 2018 to 2020.
Glenn D. Steele, Jr, MD, PhD
Robert Stone
“City of Hope has benefited from Glenn’s vision, expertise, and leadership on our board for a
number of years,” said City of Hope President and Chief Executive Officer Robert Stone. “His background and accomplishments as an academic physician-scientist have played an important role in propelling our research and innovative patient care. He will carry on the exceptional work of our immediate Past Chair, Selwyn Isakow, founder and Chief Executive Officer of The Oxford Investment Group, to lead City of Hope into the future.”
“City of Hope is an extraordinary organization at the center of eliminating cancer and diabetes,” said Dr. Steele, “and I am honored to be elected as Board Chair.” Dr. Steele serves as Chairman of GSteele Health Solutions, an independently operated venture launched to help health-care organizations create value and improve quality. He is the former Chairman of xG Health Solutions and former President and Chief Executive Officer of Geisinger Health System, an integrated health services organization recognized for its innovative use of the electronic health record and the development and implementation of leading-edge care models.
Extensive Background in Leadership
Dr. Steele is Past Chairman of the American Board of Surgery and serves on numerous for-profit and not-for-profit boards and national committees. He is a member of the National Academy of Medicine, and his academic leadership positions include Dean of the Biological Sciences Division and the Pritzker School of Medicine and Vice President for Medical Affairs at University of Chicago as well as the Richard T. Crane Professor in the Department of Surgery. Prior to that, Dr. Steele was the William V. McDermott Professor of Surgery at Harvard Medical School. His investigations have focused on the cell biology of gastrointestinal cancer and precancer in addition to innovations in health-care delivery and financing. A prolific writer, Dr. Steele is the author or coauthor of more than 500 scientific and professional articles.
Dr. Steele received his bachelor’s degree in history and literature from Harvard College and his medical degree from New York University School of Medicine. He completed his internship and residency in surgery at the University of Colorado, where he was also a fellow of the American Cancer Society. He earned his doctorate in microbiology at Lund University in Sweden.
